Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo
Authors
Keywords
-
Journal
LEUKEMIA
Volume 29, Issue 11, Pages 2173-2183
Publisher
Springer Nature
Online
2015-05-19
DOI
10.1038/leu.2015.124
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma
- (2015) Nicola Amodio et al. Oncotarget
- In Vitro and in Vivo Anti-tumor Activity of miR-221/222 Inhibitors in Multiple Myeloma
- (2015) Maria Teresa Di Martino et al. Oncotarget
- Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity
- (2015) Lavinia Raimondi et al. Oncotarget
- Dual mechanisms by which miR-125b represses IRF4 to induce myeloid and B-cell leukemias
- (2014) A. Y.-L. So et al. BLOOD
- miR-30-5p Functions as a Tumor Suppressor and Novel Therapeutic Tool by Targeting the Oncogenic Wnt/β-Catenin/BCL9 Pathway
- (2014) Jian-Jun Zhao et al. CANCER RESEARCH
- MicroRNA and Multiple Myeloma: from Laboratory Findings to Translational Therapeutic Approaches
- (2014) Marco Rossi et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- A p53-Dependent Tumor Suppressor Network Is Induced by Selective miR-125a-5p Inhibition in Multiple Myeloma Cells
- (2014) Marzia Leotta et al. JOURNAL OF CELLULAR PHYSIOLOGY
- In Vitro and In Vivo Activity of a Novel Locked Nucleic Acid (LNA)-Inhibitor-miR-221 against Multiple Myeloma Cells
- (2014) Maria Teresa Di Martino et al. PLoS One
- In Vivo Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma
- (2014) Maria Teresa Di Martino et al. PLoS One
- Transferrin-Conjugated SNALPs Encapsulating 2′-O-Methylated miR-34a for the Treatment of Multiple Myeloma
- (2014) Immacolata Scognamiglio et al. Biomed Research International
- Mir-34: A New Weapon Against Cancer?
- (2014) Gabriella Misso et al. Molecular Therapy-Nucleic Acids
- Control of Autophagic Cell Death by Caspase-10 in Multiple Myeloma
- (2013) Laurence Lamy et al. CANCER CELL
- miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells
- (2013) Nicola Amodio et al. CELL CYCLE
- Attenuation of dexamethasone-induced cell death in multiple myeloma is mediated by miR-125b expression
- (2013) Megan Murray et al. CELL CYCLE
- Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth
- (2013) E. Leone et al. CLINICAL CANCER RESEARCH
- Biological and Clinical Relevance of miRNA Expression Signatures in Primary Plasma Cell Leukemia
- (2013) M. Lionetti et al. CLINICAL CANCER RESEARCH
- Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma
- (2013) Nicola Amodio et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication
- (2013) I. Misiewicz-Krzeminska et al. HAEMATOLOGICA
- Diverse functions of miR-125 family in different cell contexts
- (2013) Yu-Meng Sun et al. Journal of Hematology & Oncology
- ERK-Dependent Downregulation of Skp2 Reduces Myc Activity with HGF, Leading to Inhibition of Cell Proliferation through a Decrease in Id1 Expression
- (2013) X. Li et al. MOLECULAR CANCER RESEARCH
- Addiction to c-MYC in multiple myeloma
- (2012) T. Holien et al. BLOOD
- Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence
- (2012) M. T. Di Martino et al. CLINICAL CANCER RESEARCH
- Molecular Targets for the Treatment of Multiple Myeloma
- (2012) Marco Rossi et al. CURRENT CANCER DRUG TARGETS
- Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma
- (2012) P. Tagliaferri et al. CURRENT CANCER DRUG TARGETS
- miR-29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma-related bone disease
- (2012) Marco Rossi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Molecular pathogenesis of multiple myeloma and its premalignant precursor
- (2012) W. Michael Kuehl et al. JOURNAL OF CLINICAL INVESTIGATION
- MiR-125 in normal and malignant hematopoiesis
- (2012) L Shaham et al. LEUKEMIA
- MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R
- (2012) J Gong et al. ONCOGENE
- miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1
- (2012) N Amodio et al. Cell Death & Disease
- miR-34 – a microRNA replacement therapy is headed to the clinic
- (2012) Andreas G. Bader Frontiers in Genetics
- Pathogenesis of Myeloma
- (2011) Kenneth C. Anderson et al. Annual Review of Pathology-Mechanisms of Disease
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- MicroRNA-125b Potentiates Macrophage Activation
- (2011) Aadel A. Chaudhuri et al. JOURNAL OF IMMUNOLOGY
- A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells
- (2011) T Calimeri et al. LEUKEMIA
- Treatment of multiple myeloma
- (2011) S. Vincent Rajkumar Nature Reviews Clinical Oncology
- NAViGaTing the Micronome – Using Multiple MicroRNA Prediction Databases to Identify Signalling Pathway-Associated MicroRNAs
- (2011) Elize A. Shirdel et al. PLoS One
- Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development
- (2010) Flavia Pichiorri et al. CANCER CELL
- MicroRNA 125b inhibition of B cell differentiation in germinal centers
- (2010) Murali Gururajan et al. INTERNATIONAL IMMUNOLOGY
- IL-6-induced Enhancement of c-Myc Translation in Multiple Myeloma Cells
- (2010) Yijiang Shi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting microRNAs in cancer: rationale, strategies and challenges
- (2010) Ramiro Garzon et al. NATURE REVIEWS DRUG DISCOVERY
- Negative regulation of the tumor suppressor p53 gene by microRNAs
- (2010) M Kumar et al. ONCOGENE
- IRF4: Immunity. Malignancy! Therapy?
- (2009) A. L. Shaffer et al. CLINICAL CANCER RESEARCH
- MicroRNAs as potential cancer therapeutics
- (2009) P Trang et al. ONCOGENE
- Stress and IGF-I Differentially Control Cell Fate through Mammalian Target of Rapamycin (mTOR) and Retinoblastoma Protein (pRB)
- (2008) Melissa Popowski et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bone marrow microenvironment and the identification of new targets for myeloma therapy
- (2008) K Podar et al. LEUKEMIA
- IRF4 addiction in multiple myeloma
- (2008) Arthur L. Shaffer et al. NATURE
- MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
- (2008) F. Pichiorri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started